GEA Group Reports Third Quarter 2026 Financial Results

GEA Group reported a strong third quarter for 2026, characterized by a significant rise in order intake to 1.65 billion euros, driven by major projects in the nutrition and pharmaceutical sectors. Revenue for the quarter grew by 7.0 percent to 1.46 billion euros, while the EBITDA before restructuring expenses increased by 12.6 percent to 260.9 million euros, resulting in an operating margin of 17.9 percent. Despite missing some market growth expectations, the company confirmed its full-year guidance, which includes organic revenue growth of 6.0 to 8.0 percent and an EBITDA margin before restructuring of 17.0 to 17.4 percent. Management attributed the performance to strong demand and customer investment in GEA's process technologies.